Isabel Gonçalves

Isabel Gonçalves

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2023 in Pediatric Transplantation
Verified
Journal Article
Closed access
CCCatarina Cordeiro
Catarina Cordeiro
SFSandra Ferreira
Sandra Ferreira
SNSusana Nobre
Susana Nobre
CCCatarina Cunha
Catarina Cunha
MJMaria José Julião
Maria José Julião
IGIsabel Gonçalves
Isabel Gonçalves

28 March 2025 in JHEP Reports
Verified
Journal Article
Open access
KWKarsten Vanden Wyngaert
Karsten Vanden Wyngaert
JSJanne Suykens
Janne Suykens
DKDeirdre Kelly
Deirdre Kelly
IGIsabel Gonçalves
Isabel Gonçalves
ETEna Lindhart Thomsen
Ena Lindhart Thomsen
RBRuth De Bruyne
Ruth De Bruyne
The transfer journey from pediatric to adult care services of young people with rare liver diseases poses significant challenges and is an underexplored research area. This study examined the critical aspects of, and opportunities for, transfer journey management for these young people in Europe. In total, 72 individuals, representing 13 countries, participated in an omnistakeholder workshop on 17–18 March 2023. A standardized workshop methodology was used to discuss critical aspects and actions over nine focus sessions. The themes of these sessions were identified by engaging with healthcare providers, young people, and parents. Results (i.e. aspects receiving >25% of the votes) were ranked based on importance and validated by the European Reference Network of Hepatological Diseases (ERN RARE-LIVER) youth panel. Our findings revealed that the critical aspects of transfer journey management predominantly revolved around the transfer itself. Most of the critical aspects and actions were related to improving communication (e.g. allocating sufficient time, 81% of votes; giving consistent information, 43%; and discussing communication preferences, 100%), relational continuity (e.g. appointing a transition person to liaison between stakeholders, 79%), and management continuity (e.g. using a transfer document, 60%). Our results also underscored the importance of peer mentorship programs (100%), informing young people about the transfer process (85%), and implementing joint consultations (93%). Current literature and guidelines on ‘transition’ might not fully address real-world challenges in rare liver diseases, particularly those concerning maintaining continuity of care during the actual transfer process. Future research should examine the effectiveness of strategies aimed at enhancing communication and continuity of care throughout the transfer journey, focusing on stakeholder experience. This international omnistakeholder workshop explored challenges and opportunities in managing transfer journeys for young people with rare liver diseases. By emphasizing practical implications (leading to actions), it provides a benchmark for improving transfer journeys worldwide, applicable to not only rare liver diseases, but possibly also common liver or other rare diseases. Our findings underscore the fundamental importance of the transfer itself in maintaining continuity of care. The critical aspects identified center around informative, relational, and management continuity of care and have been transformed into minimal criteria.

21 September 2023 in Eurosurveillance
Verified
Journal Article
Open access
BGBerta Grau-Pujol
Berta Grau-Pujol
JMJoão Vieira Martins
João Vieira Martins
IGIsabel Gonçalves
Isabel Gonçalves
FRFernanda Rodrigues
Fernanda Rodrigues
RSRita De Sousa
Rita De Sousa
PVPaula Vasconcelos
Paula Vasconcelos
On 5 April 2022, the United Kingdom reported an increase of cases of severe acute hepatitis of unknown aetiology in children, several needing hospitalisation and some required liver transplant or died. Thereafter, 35 countries reported probable cases, almost half of them in Europe. Facing the alert, on 28 April, Portugal created a multidisciplinary Task Force (TF) for rapid detection of probable cases and response. The experts of the TF came from various disciplines: clinicians, laboratory experts, epidemiologists, public health experts and national and international communication. Moreover, Portugal adopted the European Centre for Disease Prevention and Control (ECDC) and the World Health Organization (WHO) case definition and recommendations. By 31 December 2022, 28 probable cases of severe acute hepatitis of unknown aetiology were reported: 16 male and 17 aged under 2 years. Of these cases, 23 were hospitalised but none required liver transplant or died. Adenovirus was detected from nine of 26 tested cases. No association was observed between adenovirus infection and hospital admission after adjusting for age, sex and region in a binomial regression model. The TF in Portugal may have contributed to increase awareness among clinicians, enabling early detection and prompt management of the outbreak.

Verified
Journal Article
Open access
PDF file
Rui Caetano OliveiraRui Caetano Oliveira
Rui Caetano Oliveira
SFSandra Ferreira
Sandra Ferreira
IGIsabel Gonçalves
Isabel Gonçalves
MMMaria de Fátima Martins
Maria de Fátima Martins
Despite looking monotonous, liver histology represents a highly complex structure of hepatocytes, bile ducts and vessels. This complex interaction and development originate in embryology and remain in adult life. In this manuscript, we highlight the features of liver embryology, translating the events into pathologic features and opening possibilities for disease understanding and research. We revisit liver embryology, from biliary to vascular processes, stressing some developing abnormalities with a focus on the histological findings. With this manuscript, we hope to increase the awareness of the importance of embryology in diseases, prompting its detailed study.